Literature DB >> 1561589

Crack cocaine and the exchange of sex for money or drugs. Risk factors for gonorrhea among black adolescents in San Francisco.

S K Schwarcz1, G A Bolan, M Fullilove, J McCright, R Fullilove, R Kohn, R T Rolfs.   

Abstract

In contrast to rates for the United States as a whole, the incidence rate of gonorrhea increased 11% in San Francisco between 1986 and 1988, with substantial increases observed among black adolescents. Reports by health department personnel and police suggested that crack cocaine use, specifically the exchange of sex for drugs, contributed to this increase. To test this hypothesis, the authors conducted a case-control study from August 1988 to October 1988 that compared 68 prospectively identified adolescent gonorrhea patients with 136 neighborhood control patients. Thirty-two percent of the female gonorrhea patients had received money or drugs in exchange for sex, while none of the control patients reported having done so (P = 0.0001). Most of the female patients (89%) who had received money or drugs in exchange for sex had used crack. Crack use was less common among female patients who denied receiving money or drugs in exchange for sex (11%) and among control patients (6%). Crack use and providing money or drugs in exchange for sex were not risk factors for gonorrhea among the male patients, but were reported frequently by both gonorrhea patients and control patients. Not living with parents was a risk factor for male patients (odds ratio 4.9, 95% confidence limit 1.4 to 19.5). For all patients, a history of a sexually transmitted disease appeared to be an independent risk factor for gonorrhea. The conclusion is made that crack-related exchange of sex for money or drugs is a risk factor for gonorrhea among black adolescent girls in San Francisco.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561589     DOI: 10.1097/00007435-199201000-00002

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Demographic and behavioural profile of adults infected with chlamydia: a case-control study.

Authors:  K W Radcliffe; S Ahmad; G Gilleran; J D Ross
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Racial/ethnic disparities in the HIV and substance abuse epidemics: communities responding to the need.

Authors:  H Amaro; A Raj; R R Vega; T W Mangione; L N Perez
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

3.  Coming home from jail: the social and health consequences of community reentry for women, male adolescents, and their families and communities.

Authors:  Nicholas Freudenberg; Jessie Daniels; Martha Crum; Tiffany Perkins; Beth E Richie
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

4.  Syphilis, gonorrhoea, and drug abuse among pregnant women in Jefferson County, Alabama, US, 1980-94: monitoring trends through systematically collected health services data.

Authors:  S H Ebrahim; W W Andrews; A A Zaidi; W C Levine; M B DuBard; R L Goldenberg
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

Review 5.  Racial disparities in preterm births. The role of urogenital infections.

Authors:  K Fiscella
Journal:  Public Health Rep       Date:  1996 Mar-Apr       Impact factor: 2.792

6.  Sexual risk profiles of delinquent and homeless youths.

Authors:  M L Forst
Journal:  J Community Health       Date:  1994-04

Review 7.  Group sex events amongst non-gay drug users: an understudied risk environment.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval
Journal:  Int J Drug Policy       Date:  2010-08-25

8.  Coming home from jail: the social and health consequences of community reentry for women, male adolescents, and their families and communities.

Authors:  Nicholas Freudenberg; Jessie Daniels; Martha Crum; Tiffany Perkins; Beth E Richie
Journal:  Am J Public Health       Date:  2008-09       Impact factor: 9.308

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.